Alternatives to Ultima Genomics

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Advanced infectious disease diagnostics

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Revolutionizing genomic analysis with innovative sequencing technology.

AI-driven digital twin of embryo development for cell-based therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Life sciences data platform for deep-phenotype multi-omics datasets.

Dot Compliance provides an AI-powered eQMS for life sciences companies to accelerate product delivery and reduce costs.

Developing novel therapeutics for rare genetic diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.